Page last updated: 2024-08-23

simvastatin and Anasarca

simvastatin has been researched along with Anasarca in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (33.33)29.6817
2010's7 (58.33)24.3611
2020's1 (8.33)2.80

Authors

AuthorsStudies
Kourounakis, AP; Matralis, AN1
Barbirato, DDS; Diniz, JA; do Nascimento, EHL; Dourado, ACAG; Laureano Filho, JR; Pontual, ADA1
Aghajanzadeh, M; Andalib, S; Danafar, H; Shirinzadeh, A; Zamani, M1
Huang, CJ; Kao, MC; Li, KY; Shih, PC; Tsai, PS; Yang, CH1
Ding, HJ; Ong, SG1
Basta-Jovanović, G; Chatterjee, PK; Nesic, Z; Prostran, M; Radojevic-Skodrić, S; Stojanović, R; Thiemermann, C; Todorovic, Z; Velicković, R1
Dobrić, S; Jaćević, V; Milovanović, ZA; Nezić, L; Satara, SS; Skrbić, R; Stojaković, N; Stojiljković, MP1
Bersani-Amado, CA; Bracht, L; Caparroz-Assef, SM; Cuman, RK; Magon, TF; Ritter, AM1
Boyd, AR; Hinojosa, CA; Orihuela, CJ; Rodriguez, PJ1
Cheng, YT; Gao, RL; Geng, YJ; Li, XD; Yang, YJ; Yuan, JQ; Zhang, HT; Zhao, JL1
Barbier, O; Blanquart, C; Briand, O; Dombrowicz, D; Duhem, C; Fruchart, JC; Glineur, C; Paumelle, R; Percevault, F; Staels, B; Woerly, G1
Cakmak, A; Demirpençe, E; Deniz Dinçer, U; Köksoy, A; Köksoy, C; Okcu-Heper, A; Oziş, E; Yazgan, U1

Trials

1 trial(s) available for simvastatin and Anasarca

ArticleYear
Tomographic evaluation of the effect of simvastatin topical use on alveolar bone microarchitecture, pain and swelling after mandibular third molar extraction: a randomized controlled trial.
    Clinical oral investigations, 2022, Volume: 26, Issue:4

    Topics: Alveolar Bone Loss; Alveolar Ridge Augmentation; Edema; Humans; Molar, Third; Pain; Simvastatin; Single-Blind Method; Tooth Extraction; Tooth Socket

2022

Other Studies

11 other study(ies) available for simvastatin and Anasarca

ArticleYear
Design of novel potent antihyperlipidemic agents with antioxidant/anti-inflammatory properties: exploiting phenothiazine's strong antioxidant activity.
    Journal of medicinal chemistry, 2014, Mar-27, Volume: 57, Issue:6

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Atherosclerosis; Biphenyl Compounds; Carrageenan; Cholesterol, Dietary; Cyclooxygenase Inhibitors; Diet, High-Fat; Drug Design; Edema; Enzyme Inhibitors; Farnesyl-Diphosphate Farnesyltransferase; Hypolipidemic Agents; In Vitro Techniques; Indicators and Reagents; Lipid Peroxidation; Magnetic Resonance Spectroscopy; Male; Mice; Microsomes; Phenothiazines; Picrates; Rats

2014
In vivo study of mPEG-PCL as a nanocarriers for anti-inflammatory drug delivery of simvastatin.
    Pharmaceutical development and technology, 2019, Volume: 24, Issue:6

    Topics: Animals; Anti-Inflammatory Agents; Anticholesteremic Agents; Drug Carriers; Drug Delivery Systems; Edema; Male; Micelles; Polyesters; Polyethylene Glycols; Rats, Wistar; Simvastatin

2019
Simvastatin attenuates sepsis-induced blood-brain barrier integrity loss.
    The Journal of surgical research, 2015, Volume: 194, Issue:2

    Topics: Animals; Blood Pressure; Blood-Brain Barrier; Brain; Brain Diseases; Chemokine CXCL2; Claudin-3; Claudin-5; Drug Evaluation, Preclinical; Edema; Heart Rate; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Interleukin-6; Male; Malondialdehyde; Oxidative Stress; Random Allocation; Rats, Sprague-Dawley; Sepsis; Simvastatin; Survival Rate

2015
Patient with statin-associated immune-mediated necrotizing myopathy presenting with subcutaneous edema, persistent bulbar weakness and absent anti-HMGCR.
    International journal of rheumatic diseases, 2017, Volume: 20, Issue:12

    Topics: Aged; Autoantibodies; Azathioprine; Biopsy; Bulbar Palsy, Progressive; Edema; Glucocorticoids; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Male; Muscle Weakness; Muscle, Skeletal; Muscular Diseases; Necrosis; Prednisolone; Recovery of Function; Simvastatin; Treatment Outcome

2017
Acute protective effects of simvastatin in the rat model of renal ischemia-reperfusion injury: it is never too late for the pretreatment.
    Journal of pharmacological sciences, 2008, Volume: 107, Issue:4

    Topics: Animals; Creatinine; Disease Models, Animal; Drug Administration Schedule; Edema; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Injections, Intravenous; Kidney; Kidney Tubular Necrosis, Acute; Male; Rats; Rats, Wistar; Reperfusion Injury; Simvastatin; Sodium; Time Factors

2008
Simvastatin and indomethacin have similar anti-inflammatory activity in a rat model of acute local inflammation.
    Basic & clinical pharmacology & toxicology, 2009, Volume: 104, Issue:3

    Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Carrageenan; Disease Models, Animal; Dose-Response Relationship, Drug; Edema; Indomethacin; Inflammation; Male; Neutrophil Infiltration; Rats; Rats, Wistar; Simvastatin

2009
Topical anti-inflammatory effect of hypocholesterolaemic drugs.
    The Journal of pharmacy and pharmacology, 2011, Volume: 63, Issue:7

    Topics: Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Croton Oil; Ear; Edema; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mice; Neutrophil Infiltration; Neutrophils; Peroxidase; Simvastatin; Skin

2011
Impact of oral simvastatin therapy on acute lung injury in mice during pneumococcal pneumonia.
    BMC microbiology, 2012, May-15, Volume: 12

    Topics: Acute Lung Injury; Administration, Oral; Animals; Anticholesteremic Agents; Cytokines; Disease Models, Animal; Edema; Female; Histocytochemistry; Lung; Mice; Mice, Inbred BALB C; Pneumonia, Pneumococcal; Simvastatin; Streptococcus pneumoniae; Survival Analysis

2012
The cardioprotection of simvastatin in reperfused swine hearts relates to the inhibition of myocardial edema by modulating aquaporins via the PKA pathway.
    International journal of cardiology, 2013, Sep-10, Volume: 167, Issue:6

    Topics: Animals; Aquaporins; Cardiotonic Agents; Cyclic AMP-Dependent Protein Kinases; Edema; Myocardial Reperfusion Injury; Signal Transduction; Simvastatin; Swine; Swine, Miniature

2013
Acute antiinflammatory properties of statins involve peroxisome proliferator-activated receptor-alpha via inhibition of the protein kinase C signaling pathway.
    Circulation research, 2006, Feb-17, Volume: 98, Issue:3

    Topics: Animals; Edema; Extremities; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mice; Mice, Inbred C57BL; Mice, Knockout; PPAR alpha; Protein Kinase C; Signal Transduction; Simvastatin

2006
Simvastatin pretreatment reduces the severity of limb ischemia in an experimental diabetes model.
    Journal of vascular surgery, 2007, Volume: 45, Issue:3

    Topics: Animals; Diabetes Mellitus, Experimental; Edema; Glutathione; Hindlimb; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemia; Male; Malondialdehyde; Muscle, Skeletal; Necrosis; Peroxidase; Random Allocation; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Severity of Illness Index; Simvastatin; Time Factors; Tourniquets

2007